Myo-Inositol in Polycystic Ovary Syndrome: A Systematic Review and Positioning of Its Use

    March 2022 in “ International Journal of Nutrology ”
    Durval Ribas Filho, Carlos Alberto Nogueira‐de‐Almeida, Idiberto José Zotarelli Filho
    Studysummary This study found that myo-inositol improved fertility and metabolic parameters in women with polycystic ovary syndrome, including those undergoing in vitro fertilization, and reduced the risk of gestational diabetes.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ijn.zotarellifilhoscientificworks.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance, and Obesity Clinica Chimica Acta · 2019
    2. Insulin Sensitizer Agents Alone and in Co-Treatment with Recombinant FSH for Ovulation Induction in Women with PCOS Gynecological Endocrinology · 2009

    Related research 3

    1. Current Aspects of Polycystic Ovary Syndrome: A Literature Review Revista Da Associacao Medica Brasileira · 2016
    2. Caring for Women with Polycystic Ovary Syndrome The Nurse Practitioner · 2016
    3. Screening for Diabetes in Women with Polycystic Ovary Syndrome Canadian Medical Association Journal · 2007